Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypes

Abstract Background In the era of therapeutic de-escalation, the opportunity to move from systematic axillary lymph node dissection (ALND) to sentinel lymph node biopsy in axillary node-positive breast cancer patients after neoadjuvant systemic therapy (NST) is currently considered. The purpose of t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Loup Guichard, Prescillia Nunes, Clémentine Jankowski, Aurélie Bertaut, Eloïse Michel, Sylvain Ladoire, Charles Coutant, Alexandre Cochet, Jean-Louis Alberini
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-09-01
Col·lecció:	Cancer Imaging
Matèries:	Breast cancer Neoadjuvant therapy FDG PET Axillary lymph node Response monitoring Tumor subtype
Accés en línia:	https://doi.org/10.1186/s40644-025-00914-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!